homovanillic acid has been researched along with Atrophy in 17 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Schizophrenic patients with high ventricle brain ratios and cortical brain atrophy, as shown by computerized tomography, had decreased spinal fluid concentrations of homovanillic acid and dopamine-beta-hydroxylase activity." | 7.66 | Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. ( Linnoila, M; Mann, LS; Marder, SR; Ninan, PT; Rieder, RO; Scheinin, M; Sternberg, DE; van Kammen, DP; van Kammen, WB, 1983) |
| "Patients with neurogenic orthostatic hypotension due to multiple system atrophy (MSA) or pure autonomic failure (PAF) excrete lower amounts of homovanillic acid (HVA) than do normal subjects." | 3.67 | Relationship between urinary excretion of homovanillic acid and norepinephrine metabolites in normal subjects and patients with orthostatic hypotension. ( Kopin, IJ; Oliver, JA; Polinsky, RJ, 1988) |
| "In 16 patients with chronic schizophrenia, cerebrospinal fluid (CSF) concentrations of homovanillic acid (HVA) showed a significant negative correlation with computed tomographic measures of brain third ventricle size." | 3.67 | Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia. ( Bowden, CL; Contreras, SA; Houston, JP; Javors, MA; Maas, JW; McIntyre, KL, 1986) |
| "Schizophrenic patients with high ventricle brain ratios and cortical brain atrophy, as shown by computerized tomography, had decreased spinal fluid concentrations of homovanillic acid and dopamine-beta-hydroxylase activity." | 3.66 | Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. ( Linnoila, M; Mann, LS; Marder, SR; Ninan, PT; Rieder, RO; Scheinin, M; Sternberg, DE; van Kammen, DP; van Kammen, WB, 1983) |
| "Baseline concentrations of homovanillic acid (HVA), 5-hydroxyindole acetic acid (5-HIAA) and MHPG in the cerebrospinal fluid (CSF) were determined in 67 lobotomized and 30 non-lobotomized patients with chronic schizophrenia." | 3.66 | Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients. ( Hyyppä, S; Kampman, R; Myllylä, V; Ranta, P; Rimón, R; Roos, BE, 1979) |
| "Biogenic amines synthesis in phenylketonuria (PKU) patients with high phenylalanine (Phe) concentration is thought to be impaired due to inhibition of tyrosine and tryptophan hydroxylases and competition with amino acids at the blood-brain barrier." | 1.51 | Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria. ( Berg, D; Blau, N; Burgard, P; Deuschl, C; Freisinger, P; Georg, H; Gramer, G; Haas, D; Kölker, S; Leks, E; Nawroth, P; Piel, D; Pilotto, A; Scheffler, K; Schulte, C; Trefz, F; Zipser, C, 2019) |
| "We conclude that in the majority of vascular dementias subcortical damage seems to have a major pathogenetic role." | 1.28 | Is multi-infarct dementia representative of vascular dementias? A retrospective study. ( Cadini, D; Caputo, N; Gaiti, A; Longo, A; Mecocci, P; Parnetti, L; Petrini, A; Santucci, C; Senin, U; Signorini, E, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilotto, A | 1 |
| Blau, N | 1 |
| Leks, E | 1 |
| Schulte, C | 1 |
| Deuschl, C | 1 |
| Zipser, C | 1 |
| Piel, D | 1 |
| Freisinger, P | 1 |
| Gramer, G | 1 |
| Kölker, S | 1 |
| Haas, D | 1 |
| Burgard, P | 1 |
| Nawroth, P | 1 |
| Georg, H | 1 |
| Scheffler, K | 1 |
| Berg, D | 1 |
| Trefz, F | 1 |
| van Bregt, DR | 1 |
| Thomas, TC | 1 |
| Hinzman, JM | 1 |
| Cao, T | 1 |
| Liu, M | 1 |
| Bing, G | 1 |
| Gerhardt, GA | 1 |
| Pauly, JR | 1 |
| Lifshitz, J | 1 |
| Gibson, KM | 1 |
| Gupta, M | 1 |
| Pearl, PL | 1 |
| Tuchman, M | 1 |
| Vezina, LG | 1 |
| Snead, OC | 1 |
| Smit, LM | 1 |
| Jakobs, C | 1 |
| García-Cazorla, A | 1 |
| Serrano, M | 1 |
| Pérez-Dueñas, B | 1 |
| González, V | 1 |
| Ormazábal, A | 1 |
| Pineda, M | 1 |
| Fernández-Alvarez, E | 1 |
| Campistol, JM | 1 |
| Artuch, RM | 1 |
| van Kammen, DP | 3 |
| Mann, LS | 2 |
| Sternberg, DE | 1 |
| Scheinin, M | 1 |
| Ninan, PT | 2 |
| Marder, SR | 1 |
| van Kammen, WB | 2 |
| Rieder, RO | 1 |
| Linnoila, M | 3 |
| Yamamoto, M | 1 |
| Otsuki, S | 1 |
| Miyake, K | 1 |
| Namba, R | 1 |
| del Ser, T | 1 |
| Kuriwaka, R | 1 |
| Mitsui, T | 1 |
| Fujiwara, S | 1 |
| Nishida, Y | 1 |
| Matsumoto, T | 1 |
| Rimón, R | 1 |
| Roos, BE | 1 |
| Kampman, R | 1 |
| Hyyppä, S | 1 |
| Ranta, P | 1 |
| Myllylä, V | 1 |
| Lehmann, J | 1 |
| DeSouza, EB | 1 |
| Culp, S | 1 |
| Zaczek, R | 1 |
| Parnetti, L | 1 |
| Mecocci, P | 1 |
| Santucci, C | 1 |
| Gaiti, A | 1 |
| Petrini, A | 1 |
| Longo, A | 1 |
| Cadini, D | 1 |
| Caputo, N | 1 |
| Signorini, E | 1 |
| Senin, U | 1 |
| Peters, J | 1 |
| Yao, J | 1 |
| Neylan, T | 1 |
| Beuger, M | 1 |
| Pontius, E | 1 |
| O'Connor, DT | 1 |
| Boronow, J | 2 |
| Pickar, D | 2 |
| Roy, A | 1 |
| Hommer, D | 1 |
| Paul, SM | 1 |
| Kopin, IJ | 1 |
| Oliver, JA | 1 |
| Polinsky, RJ | 1 |
| Doran, AR | 1 |
| Weinberger, DR | 1 |
| Wolkowitz, OM | 1 |
| Breier, A | 1 |
| Seppala, T | 1 |
| Houston, JP | 1 |
| Maas, JW | 1 |
| Bowden, CL | 1 |
| Contreras, SA | 1 |
| McIntyre, KL | 1 |
| Javors, MA | 1 |
1 review available for homovanillic acid and Atrophy
| Article | Year |
|---|---|
[Clinical manifestation of frontotemporal dementia].
Topics: Alzheimer Disease; Atrophy; Cognition Disorders; Diagnosis, Differential; Frontal Lobe; Homovanillic | 2000 |
16 other studies available for homovanillic acid and Atrophy
| Article | Year |
|---|---|
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.
Topics: Adult; Atrophy; Biogenic Amines; Case-Control Studies; Female; Gray Matter; Homovanillic Acid; Human | 2019 |
Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atrophy; Brain Injuries; Calcium-Binding Proteins; Carrier | 2012 |
Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Topics: Adult; Aldehyde Oxidoreductases; Atrophy; Cerebellum; Chromatography, High Pressure Liquid; Chromato | 2003 |
Secondary abnormalities of neurotransmitters in infants with neurological disorders.
Topics: 5-Hydroxytryptophan; Atrophy; Brain; Electroencephalography; Epilepsy; Female; Homovanillic Acid; Hu | 2007 |
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy.
Topics: Adolescent; Adult; Aged; Animals; Antipsychotic Agents; Atrophy; Brain; Dopamine; Dopamine beta-Hydr | 1983 |
[Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Topics: Acanthocytes; Adult; Aged; Atrophy; Brain Diseases; Chorea; gamma-Aminobutyric Acid; Homovanillic Ac | 1983 |
Loss of postural reflexes in long-term occupational solvent exposure.
Topics: Adult; Air Pollutants, Occupational; Atrophy; Cerebellum; Homovanillic Acid; Humans; Magnetic Resona | 2002 |
Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
Topics: Atrophy; Brain Diseases; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1979 |
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atr | 1992 |
Is multi-infarct dementia representative of vascular dementias? A retrospective study.
Topics: Aged; Aged, 80 and over; Atrophy; Cerebral Cortex; Dementia, Multi-Infarct; Dementia, Vascular; Fema | 1990 |
CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.
Topics: Adult; Arousal; Atrophy; Brain; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Human | 1991 |
Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
Topics: Adult; Atrophy; Brain; Cerebellum; Cerebral Cortex; Cerebral Ventricles; Female; Homovanillic Acid; | 1985 |
Relationship between urinary excretion of homovanillic acid and norepinephrine metabolites in normal subjects and patients with orthostatic hypotension.
Topics: Atrophy; Autonomic Nervous System Diseases; Dopamine; Homovanillic Acid; Humans; Hypotension, Orthos | 1988 |
Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid.
Topics: Adult; Atrophy; Cerebral Cortex; Cerebral Ventricles; Cerebral Ventriculography; Female; Homovanilli | 1987 |
Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Atrophy; Cerebral Cortex; Dopamine; Female; Homov | 1986 |
Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
Topics: Adult; Atrophy; Brain; Cerebral Ventricles; Chronic Disease; Female; Homovanillic Acid; Humans; Male | 1986 |